The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized trial of medroxyprogesterone acetate for prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.
 
Kathy S. Albain
No Relationships to Disclose
 
Joseph M. Unger
No Relationships to Disclose
 
Robert B. Livingston
No Relationships to Disclose
 
Katherine D. Crew
No Relationships to Disclose
 
Sharon P. Wilczynski
No Relationships to Disclose
 
Caryl G. Salomon
No Relationships to Disclose
 
Barbara L. Smith
No Relationships to Disclose
 
Lucas Wong
No Relationships to Disclose
 
David Campbell
No Relationships to Disclose
 
David E. Einspahr
No Relationships to Disclose
 
Garnet L Anderson
No Relationships to Disclose
 
Dawn L. Hershman
No Relationships to Disclose
 
Gary E. Goodman
No Relationships to Disclose
 
Powel Brown
No Relationships to Disclose
 
Frank L. Meyskens
Stock and Other Ownership Interests - Cancer Prevention Pharmaceuticals (I)
Patents, Royalties, Other Intellectual Property - Patents (Inst)
Travel, Accommodations, Expenses - Cancer Prevention Pharmaceuticals
 
Ronald Potkul
No Relationships to Disclose